中文名 | (1S,2S,5R,6S)-2-氨基二环[3.1.0]己烷-2,6-二羧酸 |
英文名 | Bicyclo[3.1.0]hexane-2,6-dicarboxylic acid, 2-amino-, (1S,2S,5R,6S)- (9CI) |
别名 | (1S,2S,5R,6S)-2-氨基二环[3.1.0]己烷-2,6-二羧酸 (1S,2S,5R,6S)-2-氨基双环[3.1.0]己烷-2,6-二羧酸 |
英文别名 | Eglumetad LY 354740 Eglumegad Eglumegad [INN] (1S,2S,5R,6S)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid Bicyclo[3.1.0]hexane-2,6-dicarboxylic acid, 2-amino-, (1S,2S... (1s,2s,5r,6s)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (1S,2S,5R,6S)-2-Aminobicyclo(3.1.0)hexane-2,6-dicarboxylic acid Bicyclo[3.1.0]hexane-2,6-dicarboxylic acid,2-amino-,(1S,2S,5R,6S)- Bicyclo[3.1.0]hexane-2,6-dicarboxylicacid, 2-aMino-, [1S-(1a,2b,5a,6a)]- Bicyclo[3.1.0]hexane-2,6-dicarboxylic acid, 2-amino-, (1S,2S,5R,6S)- (9CI) |
CAS | 176199-48-7 |
化学式 | C8H11NO4 |
分子量 | 185.18 |
InChI | InChI=1/C8H11NO4/c9-8(7(12)13)2-1-3-4(5(3)8)6(10)11/h3-5H,1-2,9H2,(H,10,11)(H,12,13)/t3-,4-,5-,8-/m0/s1 |
密度 | 1.569 |
熔点 | 270-271 °C |
沸点 | 376.4±32.0 °C(Predicted) |
闪点 | 181.4°C |
蒸汽压 | 1.06E-06mmHg at 25°C |
折射率 | 1.619 |
酸度系数 | 2.06±0.40(Predicted) |
存储条件 | Keep in dark place,Sealed in dry,2-8°C |
体外研究 | Eglumegad (LY354740) down-regulates spots 1014, 1822 (hypoxia up-regulated protein 1), 4513 (an isoform of protein disulfide isomerase 3), 6204, 6312, 7306 (26S proteasome non-ATPase regulatory subunit 7) and protein spots 1013 and 6005 (destrin), and up-regulates spot 6507 (collapsin response mediator protein 1) in mouse cortical neurons. |
体内研究 | Eglumegad (LY354740) (15 or 30 mg/kg, i.p.) has no effect on spatial working memory performance in Gria1 −/− or WT mice, and it has no effect on rewarded alternation testing with a short inter-trial interval in Gria1 −/− and WT mice at concentration of 30 mg/kg. Eglumegad (LY354740) (15 or 30 mg/kg, i.p.) reduces spontaneous locomotor activity in wild-type and Gria1 −/− mice. Eglumegad (LY354740) (15 mg/kg, i.p.) dreases novelty-induced hyperlocomotion in naive GluA1-KO and pre-handled GluA1-KO males, but not in females. Eglumegad (LY354740) (15 mg/kg, i.p.) significantly reduces the increased c-Fos expression of GluA1-KO males to the level of WT males, but not in of females. Eglumegad (LY354740) (10 mg/kg, i.p.) attenuates the immobilization stress-induced increase in BDNF mRNA expression in the rat mPFC. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 5.4 ml | 27.001 ml | 54.002 ml |
5 mM | 1.08 ml | 5.4 ml | 10.8 ml |
10 mM | 0.54 ml | 2.7 ml | 5.4 ml |
5 mM | 0.108 ml | 0.54 ml | 1.08 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!